GB201608587D0 - Treatment of opiod tolerance - Google Patents
Treatment of opiod toleranceInfo
- Publication number
- GB201608587D0 GB201608587D0 GBGB1608587.0A GB201608587A GB201608587D0 GB 201608587 D0 GB201608587 D0 GB 201608587D0 GB 201608587 A GB201608587 A GB 201608587A GB 201608587 D0 GB201608587 D0 GB 201608587D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- opiod
- tolerance
- opiod tolerance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1608587.0A GB201608587D0 (en) | 2016-05-16 | 2016-05-16 | Treatment of opiod tolerance |
PCT/GB2017/051361 WO2017199014A1 (en) | 2016-05-16 | 2017-05-16 | Treatment of opioid tolerance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1608587.0A GB201608587D0 (en) | 2016-05-16 | 2016-05-16 | Treatment of opiod tolerance |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201608587D0 true GB201608587D0 (en) | 2016-06-29 |
Family
ID=56320480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1608587.0A Ceased GB201608587D0 (en) | 2016-05-16 | 2016-05-16 | Treatment of opiod tolerance |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201608587D0 (en) |
WO (1) | WO2017199014A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021158317A1 (en) * | 2020-02-07 | 2021-08-12 | The Reasearch Foundation For Suny | Methods for preventing and reversing opioid analgesic tolerance in subjects with chronic pain |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593997A (en) | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
TWI338004B (en) | 2004-02-06 | 2011-03-01 | Bristol Myers Squibb Co | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
-
2016
- 2016-05-16 GB GBGB1608587.0A patent/GB201608587D0/en not_active Ceased
-
2017
- 2017-05-16 WO PCT/GB2017/051361 patent/WO2017199014A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017199014A1 (en) | 2017-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL259110A (en) | Treatment of osteoarthritis | |
IL283258A (en) | Treatment of hypoparathyroidism | |
ZA202006746B (en) | Methods of treatment | |
HK1252645A1 (en) | Massager | |
LT3122358T (en) | Combinations of fgfr- and cmet-inhibitors for the treatment of cancer | |
SG11201609652RA (en) | Treatment of polybacterials infections | |
GB201608885D0 (en) | Treatment | |
IL285882A (en) | Therapeutic uses of l-4-chlorokynurenine | |
PT3122349T (en) | Compositions for the treatment of autodigestion | |
GB201519450D0 (en) | Novel treatment | |
GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
PT3504163T (en) | Treatment of wastewater | |
IL263564B (en) | Peptides for the treatment of osteoarthritis | |
IL260094A (en) | Treatment of hand eczema | |
GB201617470D0 (en) | Novel therapy | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
GB201608587D0 (en) | Treatment of opiod tolerance | |
SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
GB201512139D0 (en) | Methods of treatment | |
IL267059A (en) | Composition for the treatment of osteoarthritis | |
GB201617107D0 (en) | Treatment | |
GB201612260D0 (en) | Treatment | |
GB201612193D0 (en) | Treatment | |
GB201609683D0 (en) | Treatment | |
GB201603752D0 (en) | Treatment of hypothyroidism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |